Cargando…
Is prior cancer history a hindrance for non-small cell lung cancer patients to participate in clinical trials?
BACKGROUND: This study aimed to explore the effect of a prior cancer history on the survivals of resected non-small cell lung cancer (NSCLC) patients. METHODS: Kaplan–Meier method with a log-rank test was used to compare overall survival (OS) and disease-free survival (DFS) between groups. Propensit...
Autores principales: | Cai, Jing-Sheng, Li, Yun, Wang, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930244/ https://www.ncbi.nlm.nih.gov/pubmed/36793002 http://dx.doi.org/10.1186/s12885-023-10551-9 |
Ejemplares similares
-
The Use of Ulipristal Acetate (Esmya) Prior to Laparoscopic Myomectomy: Help or Hindrance?
por: Mallick, Rebecca, et al.
Publicado: (2019) -
The effect of prior cancer on non‐small cell lung cancer trial eligibility
por: Herman, Michael, et al.
Publicado: (2021) -
Lymphovascular invasion: A non‐sized T descriptor for stage IA non‐small cell lung cancer
por: Cai, Jing‐Sheng, et al.
Publicado: (2022) -
Hindrances to Medical Recruiting
Publicado: (1915) -
Adherence to Clinical Guidelines for Fibromyalgia: Help or Hindrance?
por: Häuser, Winfried, et al.
Publicado: (2023)